| Financial Year |
March 31 2023 |
| Monetary Funds |
780,148,842.79 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,426,832.72 |
| Advances to Suppliers |
8,647,545.60 |
| Other Receivables |
9,800,333.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
50,776,466.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
165,529.30 |
| Total Current Assets |
850,965,549.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,452,710,595.00 |
| Under-construction Projects |
607,017.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,019,101,792.35 |
| R&D expenses |
-- |
| Goodwill |
61,888,675.18 |
| Long-Term Deferred and Prepaid Expenses |
2,745,270.57 |
| Deferred Income Tax Assets |
4,547,396.64 |
| Other Non-Current Assets |
398,390.93 |
| Sub-Total of Non-Current Assets |
4,553,134,446.51 |
| Total Assets |
5,404,099,996.23 |
| Short-Term Loans |
751,021,269.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
32,441,854.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,542,832.90 |
| Taxes Payable |
26,531,318.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,026,125.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
234,346,611.77 |
| Other Current Liabilities |
1,705,259.70 |
| Sub-Total of Current Liabilities |
1,086,732,654.02 |
| Long-term Loans |
637,901,526.40 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
23,207,209.13 |
| Deferred Income Tax Liabilities |
35,994,838.54 |
| Other Non-Current Liabilities |
388,747,400.00 |
| Sub-Total of Non-Current Liabilities |
1,112,525,976.03 |
| Total Liabilities |
2,199,258,630.05 |
| Paid-In Capital(Or Share Stock) |
978,000,000.00 |
| Capital Surplus |
1,699,802,554.92 |
| Surplus Reserve |
101,808,297.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
402,902,411.69 |
| Minority Stockholder's Interest |
21,802,180.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,183,039,185.61 |
| Owner's Equity（Stockholder's Equity） |
3,204,841,366.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,404,099,996.23 |
